News
Vertex (VERX) delivered earnings and revenue surprises of +7.14% and +0.17%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research on MSN16d
Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know
Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $470.13, moving +2.54% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 0.06% for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback